ArticleAmerican heart journal plus : cardiology research and practice2025

All-cause mortality and cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and heart failure with reduced ejection fraction.

Aravinthan Vignarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.